FDA Approves Imfinzi for Stage III NSCLCThe U.S. Food and Drug Administration (FDA) had approved Imfinzi (durvalumab) for treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors cannot be removed with surgery... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Take the Online Health Resource Survey!Managing a chronic health condition like lung cancer can be overwhelming at times. How do you find reliable information? Where do you go to find a supportive community? What features... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Newly Approved Test Can Detect Multiple Genetic Mutations in CancerThe U.S. Food and Drug Administration (FDA) has approved a new genetic test that can detect 324 different genes that are known to be involved in 5 different cancer types:... By Emily DownwardBookmark for later Reactions 0 reactions Comments0 comments
Calling All Lung Cancer Advocates!November is our month. If you have been impacted in any way by lung cancer, this is your calling to take action. This is your opportunity to take a stand... By Dusty DonaldsonBookmark for later Reactions 0 reactions Comments0 comments
Take The Mental Health Survey!Managing life with lung cancer is difficult enough, but emotional and mental challenges can also arise. Often, people aren’t just coping with one physical condition, but several, and it can... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
New Biosimilar for the Treatment of Lung Cancer ApprovedThe U.S. Food and Drug Administration (FDA) has approved the first biosimilar for the treatment of cancer: Mvasi™ (bevacizumab-awwb). Mvasi is a biosimilar to Avastin® (bevacizumab) and like Avastin, it... By Emily DownwardBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Targeted Therapy Combo for Lung Cancer TreatmentOn 6/22/17, the US Food and Drug Administration (FDA) granted full approvals to two targeted therapies to be used in combination for patients with metastaticnon-small cell lung cancer (NSCLC) with... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
New Tools & Features on LungCancer.netYou may have noticed some changes around LungCancer.net. We’re thrilled to announce that we’ve added some new features and functionality to provide an even better experience for the most important... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Take the Media Usage Survey!Managing a condition such as lung cancer is not easy and can be physically and mentally exhausting. What do you do to unwind and take your mind off coping with... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
New Study Suggests Different Screening Intervals for Men and WomenA presentation given at the European Lung Cancer Conference (ELCC) 2017 proposes that women may be able to be screened less frequently than men for lung cancer. The controversial presentation... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Keytruda for Expanded First-Line Lung Cancer TreatmentOn 5/10/17, the United States Food & Drug Administration (FDA) granted additional approved for Keytruda, a drug manufactured by Merck & Co., for the treatment of non-small cell lung cancer... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Alunbrig for ALK+ NSCLC TreatmentOn April 28, 2017, the U.S. Food and Drug Administration (FDA) approved AlunbrigTM (brigatinib) for people with ALK+metastaticnon-small cell lung cancer (NSCLC) who have progressed on or are intolerant to... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
New Lung Cancer Vaccine from Cuba Now in U.S. Clinical TrialIn 2016, the U.S. loosened its trade embargo on Cuba that has been in place since the 1960s, and this has great implications for the lung cancer community. Cuba’s Center... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
A Nasal Swab May Be the New Diagnostic Tool of Choice for Lung CancerA recent study published in the Journal of the National Cancer Institute has shed light on a potential new diagnostic measure for lung cancer that is less invasive and less... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
New Study Shows Many Lung Cancer Patients May Be Under-TreatedA new study published January 18th in the Journal of Thoracic Oncology has brought to light some discrepancies in the treatment of lung cancer over the past twenty years. Specifically... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
